Pharma Critic Skewers Homeopathy At FDA Hearing

The FDA bent over backwards to give homeopathic purveyors and advocates the bulk of a two-day hearing on the future of pseudomedicine regulation. But the FDA appears poised to act on decisions deferred for the last 25 years.